Intellia Therapeutics, Inc.

NTLAReported to SECin USCIK 0001652130Filings at SEC EDGAR

No score on this page, by design. Everything here is a fact from a public U.S. register: insider filings at the SEC (Form 4), lobbying filings under the Lobbying Disclosure Act, trades reported by members of Congress under the STOCK Act, and fund holdings in 13F filings. Our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of each filer's page, is part of the subscription. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first: every line of every Form 4 at this company that passed our review, the same lines as on the register. Reported is the day the filing reached the SEC, usually within two business days of the trade. Amounts are in U.S. dollars, as the form states them.

5
Form 4 lines at Intellia Therapeutics, Inc., most recent filing first
Filed byTypeValueReportedFiled byValueTypeSharesReported
LEONARD JOHN MPresident and CEOOpen-market sell$36,2052,785 sharesAug 24, 2026LEONARD JOHN MPresident and CEO$36,205Sell · Aug 24Open-market sell2,785Aug 24, 2026
LEONARD JOHN MPresident and CEOOpen-market sell$250,61419,890 sharesAug 24, 2026LEONARD JOHN MPresident and CEO$250,614Sell · Aug 24Open-market sell19,890Aug 24, 2026
Dulac Edward J IIIEVP, Chief Financial OfficerOpen-market sell$91,2498,111 sharesJul 24, 2026Dulac Edward J IIIEVP, Chief Financial Officer$91,249Sell · Jul 24Open-market sell8,111Jul 24, 2026
Dube Michael PVP, Chief Accounting OfficerOpen-market sell$44,3162,641 sharesJul 6, 2026Dube Michael PVP, Chief Accounting Officer$44,316Sell · Jul 6Open-market sell2,641Jul 6, 2026
Dulac Edward J IIIEVP, Chief Financial OfficerOpen-market sell$84,1864,677 sharesJul 6, 2026Dulac Edward J IIIEVP, Chief Financial Officer$84,186Sell · Jul 6Open-market sell4,677Jul 6, 2026